KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Opko Health (OPK) Cost of Revenue (2016 - 2026)

Opko Health filings provide 17 years of Cost of Revenue readings, the most recent being $78.4 million for Q1 2026.

  • On a quarterly basis, Cost of Revenue fell 26.92% to $78.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $372.0 million, a 26.03% decrease, with the full-year FY2025 number at $400.9 million, down 18.94% from a year prior.
  • Cost of Revenue hit $78.4 million in Q1 2026 for Opko Health, down from $84.4 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $470.7 million in Q4 2023 to a low of $20.3 million in Q3 2022.
  • Median Cost of Revenue over the past 5 years was $104.6 million (2025), compared with a mean of $117.4 million.
  • The widest YoY moves for Cost of Revenue: up 823.93% in 2022, down 91.61% in 2022.
  • Opko Health's Cost of Revenue stood at $194.8 million in 2022, then surged by 141.66% to $470.7 million in 2023, then crashed by 71.63% to $133.5 million in 2024, then plummeted by 36.76% to $84.4 million in 2025, then decreased by 7.09% to $78.4 million in 2026.
  • The last three reported values for Cost of Revenue were $78.4 million (Q1 2026), $84.4 million (Q4 2025), and $101.8 million (Q3 2025) per Business Quant data.